RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SEHOULI J
Collezione AOU Città della Salute di Torino

Items : 2

How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2024 Nov 4;34(11):1677-1684. doi: 10.1136/ijgc-2024-005982.

2024
AOU Città della Salute di Torino

Sehouli J; Boer J; Brand AH; Oza AM; O'Donnell J; Bennett K; Glaspool R; Lee CK; Ethier JL; Harter P; Seebacher-Shariat V; Chang TC; Cohen PA; van Gorp T; Chavez-Blanco A; Welch S; Hranovska H; O'Toole S; Lok CAR; Madariaga A; Rauh-Hain JA; Perez Fidalgo A; Tan D; Michels J; Pothuri B; Fujiwara N; Rosengarten O; Nishio H; Kim SI; et alii...

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. in British journal of cancer / Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.

2023
AOU Città della Salute di Torino
ASL Vercelli

Aglietta M; Arcangeli V; Benedetti Panici P; De Giorgi U; Zola P; Rubio-Pérez MJ; DeCensi A; Tognon G; Pardo B; Romeo M; Tasca G; Funari G; Iglesias M; Biagioli E; Mirza MR; Deryal M; Fossati R; Barretina-Ginesta MP; Herbertson R; Riniker S; Nyvang GB; Chekerov R; Churruca Galaz C; D'Incalci M; Vergote I; Berger R; Ottevanger NB; Montes A; Sessa C; et alii...